144 related articles for article (PubMed ID: 35475973)
1. Clinical Efficacy and Safety of Chinese Patent Medicine Combined with Oseltamivir for the Treatment of Adult Influenza: A Systematic Review and Meta-Analysis.
Li X; Liu B; Duan N; Xiong Y; Zhang Y; Zhang C; Lu C; Li L
Am J Chin Med; 2022; 50(4):1043-1061. PubMed ID: 35475973
[TBL] [Abstract][Full Text] [Related]
2. [Systematic review and Meta-analysis of Lianhua Qingwen preparations combined with Oseltamivir in treatment of influenza].
Yan YM; Yang XJ; Zhao CX; Li ZY; Zhao GZ; Guo YH; Li B; Liu QQ
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4238-4247. PubMed ID: 36046914
[TBL] [Abstract][Full Text] [Related]
3. Herbal Medicine Treatment for Influenza: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Choi M; Lee SH; Chang GT
Am J Chin Med; 2020; 48(7):1553-1576. PubMed ID: 33167671
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis.
Duan NF; Liu B; Li XN; Xiong YB; Zhang Y; Zhang C; Li L; Lu C; Lyu J
Front Pharmacol; 2021; 12():682732. PubMed ID: 34421591
[No Abstract] [Full Text] [Related]
5. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Li WF; Hu CC; Ding YL; Yuan B
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4505-4516. PubMed ID: 36046880
[TBL] [Abstract][Full Text] [Related]
6. Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials.
Chen W; Lim CE; Kang HJ; Liu J
PLoS One; 2011; 6(12):e28093. PubMed ID: 22164232
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese medicine for the treatment of influenza: a systematic review and meta-analysis of randomized controlled trials.
Wang C; Wang H; Liu X; Xu D; Tang Y; Luo P
J Tradit Chin Med; 2014 Oct; 34(5):527-31. PubMed ID: 25417400
[TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese Medicine Injections Combined With Oseltamivir for Influenza: Systematic Review and Network Meta-Analysis.
Peng Y; Chen Z; Li H; Han Y; Sun D; Li Y; Wu X; Chen H; Li X
Front Pharmacol; 2022; 13():848770. PubMed ID: 35935865
[No Abstract] [Full Text] [Related]
9. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials.
Liang SB; Fang M; Liang CH; Lan HD; Shen C; Yan LJ; Hu XY; Han M; Robinson N; Liu JP
Complement Ther Med; 2021 Aug; 60():102744. PubMed ID: 34091029
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Chinese patent medicine in the adjuvant treatment of prostate cancer: A Bayesian network meta-analysis.
Wang S; Zhang F; Liu J; Qin P
Medicine (Baltimore); 2024 Mar; 103(12):e37180. PubMed ID: 38517994
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Lianhuaqingwen capsule compared with oseltamivir for influenza A virus infection: a meta-analysis of randomized, controlled trials.
Zhao P; Yang HZ; Lv HY; Wei ZM
Altern Ther Health Med; 2014; 20(2):25-30. PubMed ID: 24657957
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Chinese patent medicine in the treatment of influenza: A protocol for systematic review and meta-analysis.
Liu K; Zhang Y; Song X
Medicine (Baltimore); 2021 Nov; 100(46):e27766. PubMed ID: 34797303
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza: A Systematic Review and Meta-Analysis.
Hanula R; Bortolussi-Courval É; Mendel A; Ward BJ; Lee TC; McDonald EG
JAMA Intern Med; 2024 Jan; 184(1):18-27. PubMed ID: 37306992
[TBL] [Abstract][Full Text] [Related]
14. [Clinical trials and evaluation of Chinese patent medicine for influenza].
Sheng XD; Chen Z; Ji ZC; Hu HY; Ou Y; Cao LJ; Guo LP; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2338-2342. PubMed ID: 35531681
[TBL] [Abstract][Full Text] [Related]
15. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.
Dobson J; Whitley RJ; Pocock S; Monto AS
Lancet; 2015 May; 385(9979):1729-1737. PubMed ID: 25640810
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials.
Kuo YC; Lai CC; Wang YH; Chen CH; Wang CY
J Microbiol Immunol Infect; 2021 Oct; 54(5):865-875. PubMed ID: 34020891
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
Lee J; Park JH; Jwa H; Kim YH
Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
[TBL] [Abstract][Full Text] [Related]
18. [Rapid health technology assessment of four oral Chinese patent medicines for constipation].
Li MM; Zhao H; Dai ZQ; Wu X; Xu SM; Tang XD; Liao X
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3144-3154. PubMed ID: 35851105
[TBL] [Abstract][Full Text] [Related]
19. Tanreqing Injection () for Patients with Influenza: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Qu CC; Zhao GZ; Wang XP; Xu XL; Li B; Guo YH; Liu QQ
Chin J Integr Med; 2020 Dec; 26(12):936-942. PubMed ID: 32572781
[TBL] [Abstract][Full Text] [Related]
20. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
